Terns Pharmaceuticals, Inc. (FWB:430) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$747.5M raised · US$40 a share · Jefferies +5 Dealers: Jefferies (co-lead), TD Cowen (co-lead), Leerink Partners (co-lead), Mizuho, Citizens Capital Markets, Oppenheimer & Co. Use of proceeds: Research, clinical trials, development and manufacturing of product candidates including TERN-701, pre-launch activities, working capital and general purposes | Dec 11, 2025 |